Your browser doesn't support javascript.
loading
Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine.
Ma, Liping; Wei, Shijie; Yang, Bei; Ma, Wei; Wu, Xiuli; Ji, Hongyan; Sui, Hong; Chen, Jing.
Afiliación
  • Ma L; a School of Pharmacy, Ningxia Medical University , Yinchuan, Ningxia , PR China.
  • Wei S; b Institute of Clinical Pharmacology, General Hospital of Ningxia Medical University , Yinchuan, Ningxia , PR China.
  • Yang B; a School of Pharmacy, Ningxia Medical University , Yinchuan, Ningxia , PR China.
  • Ma W; a School of Pharmacy, Ningxia Medical University , Yinchuan, Ningxia , PR China.
  • Wu X; a School of Pharmacy, Ningxia Medical University , Yinchuan, Ningxia , PR China.
  • Ji H; b Institute of Clinical Pharmacology, General Hospital of Ningxia Medical University , Yinchuan, Ningxia , PR China.
  • Sui H; a School of Pharmacy, Ningxia Medical University , Yinchuan, Ningxia , PR China.
  • Chen J; a School of Pharmacy, Ningxia Medical University , Yinchuan, Ningxia , PR China.
Pharm Biol ; 55(1): 374-380, 2017 Dec.
Article en En | MEDLINE | ID: mdl-27931149
ABSTRACT
CONTEXT CYP3A4 and P-gp together form a highly efficient barrier for orally absorbed drugs and always share the same substrates. Our previous work revealed that chrysosplenetin (CHR) significantly augmented the rat plasma level and anti-malarial efficacy of artemisinin (ART), partially due to the uncompetitive inhibition effect of CHR on rat CYP3A. But the impact of CHR on P-gp is still unknown.

OBJECTIVE:

The present study investigates whether CHR interferes with P-gp-mediated efflux of ART and elucidates the underlying mechanism. MATERIALS AND

METHODS:

P-gp-over-expressing Caco-2 cells were treated with ART (10 µM) or ART-CHR (12, 1020 µM) in ART bidirectional transport experiment. ART concentration was determined by UHPLC-MS/MS method. Healthy male ICR mice were randomly divided into nine groups (n = 6) including negative control (0.5% CMC-Na solution, 13 mL/kg), ART alone (40 mg/kg), verapamil (positive control, 40 mg/kg), ART-verapamil (11, 4040 mg/kg), CHR alone (80 mg/kg), ART-CHR (10.1, 404 mg/kg), ART-CHR (11, 4040 mg/kg), ART-CHR (12, 4080 mg/kg) and ART-CHR (14, 40160 mg/kg). The drugs were administrated intragastrically for seven consecutive days. MDR1 and P-gp expression levels in mice small intestine were examined by performing RT-PCR and western blot analysis. ABC coupling ATPase activity was also determined.

RESULTS:

After combined with CHR (12), Papp (AP-BL) and Papp (BL-AP) of ART changed to 4.29 × 10 - 8 (increased 1.79-fold) and 2.85 × 10 - 8 cm/s (decreased 1.24-fold) from 2.40 × 10 - 8 and 3.54 × 10 - 8 cm/s, respectively. Efflux ratio (PBA/PAB) declined 2.21-fold (p < 0.01) versus to ART alone. ART significantly up-regulated both MDR1 mRNA and P-gp levels compared with vehicle, while CHR in combination ratio of 01, 0.11, 11, 21 and 41 with ART, reversed them to normal levels as well as negative control (p < 0.05). The ATPase activities in ART-CHR 14 and CHR alone groups achieved a slight increase (p < 0.05) when compared with ART alone. DISCUSSION AND

CONCLUSION:

These results confirm that CHR inhibited P-gp activity and reverse the up-regulated P-gp and MDR1 levels induced by ART. It suggested that CHR potentially can be used as a P-gp reversal agent to obstruct ART multidrug resistance.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Flavonoides / ARN Mensajero / Colon / Subfamilia B de Transportador de Casetes de Unión a ATP / Artemisininas / Intestino Delgado Límite: Animals / Humans / Male Idioma: En Revista: Pharm Biol Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Flavonoides / ARN Mensajero / Colon / Subfamilia B de Transportador de Casetes de Unión a ATP / Artemisininas / Intestino Delgado Límite: Animals / Humans / Male Idioma: En Revista: Pharm Biol Año: 2017 Tipo del documento: Article